Large clinical trial finds pirfenidone may help lung function in IPF patients

A large, well-controlled, multi-national clinical trial program has demonstrated the effectiveness and safety of what may become the first FDA-approved medicine for idiopathic pulmonary fibrosis, or IPF.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news161787643.html">Large clinical trial finds pirfenidone may help lung function in IPF patients</a></p> <p>A large, well-controlled, multi-national clinical trial program has demonstrated the effectiveness and safety of what may become the first FDA-approved medicine for idiopathic pulmonary fibrosis, or IPF.</p>